Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-25 @ 3:39 AM
NCT ID:
NCT00347802
Eligibility Criteria:
Inclusion Criteria:
* · Male or female \> 18 years of age
* Naive to treatment or washed off any ocular hypotensive agents
* Untreated IOP \>19 mm Hg
* Diagnosis of open-angle glaucoma or ocular hypertension
* Ability to provide informed consent and likely to complete study
Exclusion Criteria:
* · Known contraindication to bimatoprost or travoprost, or any component of any study medication
* Uncontrolled systemic disease
* Active ocular disease other than glaucoma or ocular hypertension
* Required use of ocular medications other than the study medications during the study
* History of intraocular surgery within the last 3 months
* Prior discontinuation of any of the study medications for reasons related to efficacy or safety
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00347802
Study Brief:
Protocol Section:
NCT00347802